Description

tert-Butyl 1-Methyl-5-Oxo-1,5,6,7-Tetrahydrospiro[Piperidine-4,4-Pyrrolo[2,3-C]Pyridine]-1-Carboxylate (Wxc00569) is a high-purity, advanced pharmaceutical intermediate featuring a complex spirocyclic and fused heterocyclic architecture. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for synthesizing novel bioactive molecules. It is primarily sought after by R&D teams and process chemists in the pharmaceutical and biotechnology industries for the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new drug candidates, particularly in oncology and central nervous system (CNS) disorders.
• Medicinal Chemistry Research: Used as a sophisticated scaffold for structure-activity relationship (SAR) studies and lead optimization programs.
• Process Chemistry Development: Serves as a critical intermediate in scaling up synthetic routes from laboratory to pilot and commercial production scales.
• Proteolysis Targeting Chimera (PROTAC) Development: Potential use as a component in the design of heterobifunctional molecules for targeted protein degradation.
• Kinase Inhibitor Synthesis: The pyrrolopyridine core structure is relevant for the synthesis of potential kinase inhibitors.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services for the global pharmaceutical market.

Basic Information

Product Name	tert-Butyl 1-Methyl-5-Oxo-1,5,6,7-Tetrahydrospiro[Piperidine-4,4-Pyrrolo[2,3-C]Pyridine]-1-Carboxylate (Wxc00569)
CAS No.	1956364-86-5
Molecular Formula	C17H25N3O3
Molecular Weight	319.40 g/mol
Synonyms	1-(1,1-Dimethylethyl) 1-Methyl-5-oxo-1,5,6,7-tetrahydrospiro[piperidine-4,4'-pyrrolo[2,3-c]pyridine]-1-carboxylate; tert-Butyl 1-methyl-5-oxo-6,7-dihydro-1H-spiro[piperidine-4,4'-pyrrolo[2,3-c]pyridine]-1-carboxylate; WXC-00569; WXC00569; 1956364-86-5; Spiro[piperidine-4,4'-pyrrolo[2,3-c]pyridine] intermediate; BOC-protected spirocyclic pyrrolopyridine.
EINECS	Contact for details

Quality Control

Our tert-Butyl 1-Methyl-5-Oxo-1,5,6,7-Tetrahydrospiro[Piperidine-4,4-Pyrrolo[2,3-C]Pyridine]-1-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with every shipment to ensure full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled accordingly. Keep away from strong acids and incompatible organic solvents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Assay	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.